Global Biliary Stents Market Size By Type (Metal Stents, Plastic Stents), By Application (Metal Stents, Plastic Stents), By Region, And Segment Forecasts, 2023 to 2032

The Global Biliary Stents Market was valued at USD 425 million in 2023 and is projected to surpass USD 750 million by 2031, registering a CAGR of 7.2% during the forecast period from 2023 to 2031. The increasing prevalence of biliary disorders, such as bile duct obstruction, gallstones, and pancreatic cancer, is driving the demand for biliary stents. Technological advancements, such as drug-eluting stents and biodegradable stents, are also contributing to the market expansion. The growing geriatric population, coupled with a rising number of minimally invasive procedures, further supports the market's growth.

Drivers

Rising Prevalence of Biliary Disorders

The increasing incidence of biliary tract diseases, including cholangiocarcinoma (bile duct cancer), pancreatitis, and gallbladder stones, is a primary driver for market growth. The need for effective palliative care in bile duct obstructions is fueling the adoption of self-expandable and metallic biliary stents.

Growing Adoption of Minimally Invasive Procedures

Biliary stenting is widely used in endoscopic retrograde cholangiopancreatography (ERCP), a minimally invasive technique to treat bile duct blockages. The shift from open surgeries to minimally invasive procedures is significantly boosting the demand for biliary stents.

Advancements in Stent Technology

Innovations such as biodegradable stents, anti-microbial coatings, and drug-eluting biliary stents are improving patient outcomes and reducing complications. These advancements enhance the durability, flexibility, and safety of biliary stents, increasing their adoption.

Restraints

High Costs of Biliary Stent Procedures

The cost of biliary stents and ERCP procedures remains a significant barrier, particularly in developing countries. Reimbursement challenges and the high price of advanced stent types limit their accessibility.

Complications Associated with Stent Placement

Despite advancements, complications such as stent occlusion, migration, and infection continue to pose challenges. The need for frequent stent replacements in certain cases can lead to higher medical costs and discomfort for patients.

Opportunity

Expansion in Emerging Markets

The Asia-Pacific and Latin America regions present lucrative growth opportunities due to improving healthcare infrastructure, rising awareness, and increasing government investments in healthcare. The higher prevalence of hepatobiliary diseases in these regions further supports market expansion.

Development of Smart and Drug-Eluting Stents

The introduction of drug-eluting biliary stents that help in reducing restenosis (re-narrowing of bile ducts) is expected to revolutionize the market. Smart stents with sensors to monitor bile flow and detect occlusions in real-time offer significant growth potential.

Market by System Type Insights

Based on system type, the Self-Expandable Metal Stents (SEMS) segment held the largest market share in 2023 due to its longer patency, reduced clogging risks, and higher efficiency in treating malignant bile duct obstructions. Plastic stents, however, remain a preferred option in short-term treatments, particularly for benign biliary diseases.

Market by End-Use Insights

Hospitals Segment Leads the Market

The Hospitals segment emerged as the largest end-user in 2023, accounting for over 60% of the market share. Hospitals are the primary centers for complex biliary stenting procedures, often handling severe bile duct obstructions, cancers, and chronic pancreatitis cases. The ambulatory surgical centers (ASCs) segment is expected to witness significant growth due to its cost-effective and patient-friendly approach for outpatient procedures.

Market by Regional Insights

North America dominated the market in 2023, owing to advanced healthcare facilities, high adoption of innovative biliary stents, and increasing prevalence of bile duct cancers.

Europe is the second-largest market, driven by technological advancements and favorable reimbursement policies.

Asia-Pacific is anticipated to witness the highest CAGR during the forecast period, with countries like China, India, and Japan investing significantly in healthcare infrastructure and minimally invasive treatments.

Competitive Scenario

Key players operating in the Global Biliary Stents Market include:

Boston Scientific Corporation

Cook Medical Inc.

Medtronic plc

Abbott Laboratories

Becton, Dickinson and Company (BD)

Taewoong Medical

CONMED Corporation

Olympus Corporation

Merit Medical Systems, Inc.

ENDO-FLEX GmbH

Companies are focusing on mergers, acquisitions, and product innovations to strengthen their market position.

Key Market Developments:

In 2023, Boston Scientific Corporation launched an advanced drug-eluting biliary stent to reduce stent occlusion rates.

In 2024, Medtronic announced a strategic partnership with leading hospitals to integrate smart biliary stents into healthcare settings.

In 2025, Cook Medical introduced a biodegradable biliary stent, reducing the need for frequent stent replacements.

Scope of Work – Global Biliary Stents Market

Report Metric Details

Market Size (2023) USD 425 million

Projected Market Size (2031) USD 750 million

CAGR (2023-2031) 7.2%

Key Segments by System Type Self-Expandable Metal Stents (SEMS), Plastic Stents

Key Segments by End-Use Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics

Leading Region North America

Key Players Boston Scientific, Cook Medical, Medtronic, Abbott, Olympus, BD, Merit Medical, Taewoong Medical

FAQs – Global Biliary Stents Market

1. What is the current market size of the Global Biliary Stents Market?

The Global Biliary Stents Market was valued at USD 425 million in 2023 and is projected to grow at a CAGR of 7.2% to reach USD 750 million by 2031.

2. What is the major growth driver of the Global Biliary Stents Market?

The increasing prevalence of biliary diseases such as cholangiocarcinoma, gallstones, and bile duct obstructions, along with the rising adoption of minimally invasive procedures, is driving market growth.

3. Which is the largest region during the forecast period in the Global Biliary Stents Market?

North America dominated the market in 2023, attributed to advanced healthcare infrastructure, higher adoption of innovative stent technologies, and increasing biliary disorder cases.

4. Which segment accounted for the largest market share in the Global Biliary Stents Market?

The Self-Expandable Metal Stents (SEMS) segment accounted for the largest market share in 2023, due to its superior durability and lower risk of occlusion.

5. Who are the key market players in the Global Biliary Stents Market?

Leading companies in the Global Biliary Stents Market include Boston Scientific, Cook Medical, Medtronic, Abbott, Olympus, BD, and Merit Medical, among others.